Bristol Myers Squibb to Participate in Bernstein’s 38th Annual Strategic Decisions Conference

Rhea-AI Summary

Bristol Myers Squibb (NYSE: BMY) will participate in a fireside chat at Bernstein’s 38th Annual Strategic Decisions Conference on June 2, 2022, at 8:00 a.m. ET in New York. Giovanni Caforio, M.D., Board Chair and CEO, along with Samit Hirawat, Chief Medical Officer, will discuss the company’s strategies. The event will be accessible via a live webcast at investor.bms.com, with an archived version available later that day. Bristol Myers Squibb focuses on developing innovative medicines for serious diseases.

NEW YORK--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the company will take part in a fireside chat at Bernstein’s 38^th Annual Strategic Decisions Conference in New York, New York on Thursday, June 2, 2022. Giovanni Caforio, M.D., Board Chair and Chief Executive Officer and Samit Hirawat, Executive Vice President, Chief Medical Officer, Global Drug Development, will answer questions about the company at 8:00 a.m. ET.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. Material related to the company’s presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

Corporatefinancial-news

View source version on businesswire.com: https://www.businesswire.com/news/home/20220526005146/en/

Bristol Myers Squibb

Media:

media@bms.com

Investor Relations:

investor.relations@bms.com

Source: Bristol Myers Squibb

FAQ

When is Bristol Myers Squibb's fireside chat at the Strategic Decisions Conference?

Bristol Myers Squibb's fireside chat is scheduled for June 2, 2022, at 8:00 a.m. ET.

Who will represent Bristol Myers Squibb at the conference?

Giovanni Caforio, M.D., Board Chair and CEO, and Samit Hirawat, Chief Medical Officer, will represent Bristol Myers Squibb.

How can I listen to the Bristol Myers Squibb conference?

The conference can be listened to via a live webcast at investor.bms.com.

Will there be an archive of the Bristol Myers Squibb conference?

Yes, an archived version of the session will be available later on the same day.

What is the focus of Bristol Myers Squibb as a company?

Bristol Myers Squibb is focused on discovering, developing, and delivering innovative medicines for serious diseases.